Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

20%

Ph not_applicable

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Other(1)

Detailed Status

Completed2

Recruiting2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (20.0%)

N/A4 (80.0%)

Trials by Status

completed240%

recruiting240%

unknown120%

Recent Activity

2 active trials

Showing 5 of 5

recruitingnot_applicable

Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

NCT07483788

completednot_applicable

Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy

NCT07276685

recruitingnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT07483788Not Applicable

Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

Recruiting

NCT07276685Not Applicable

Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy

Completed

NCT06880471Not Applicable

Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA

Recruiting

NCT01733420Phase 3

Biodentine Versus White MTA Pulpotomy

Completed

NCT03890835Not Applicable

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Unknown

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5